H. Meng

Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis

Ying Wang, Jing Chen, Xinxing Sun, 2020, Frontiers in Oncology.

Gls-010, a novel anti-PD-1 mAb in Chinese advanced gastrointestinal tumor: Result of a phase Ib clinical trial.

Z. Liu, Yingying Xu, Hui Wang, 2019, Journal of Clinical Oncology.

65P Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm, exploratory research

W. Zheng, X. Wang, Y. Xin, 2021, Annals of Oncology.

A SINGLE‐ARM, OPEN‐LABEL, PILOT TRIAL OF AUTOLOGOUS CD7‐CAR‐T CELLS FOR CD7 POSITIVE RELAPSED AND REFRACTORY T‐LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

X. Wang, Zhaoming Li, G. Pan, 2021, Hematological Oncology.

A novel recombinant human anti-PD-1 monoclonal antibody GLS-010 in patients with advanced cancer: Result of a phase Ia clinical trial

Gang Li, L. Shen, Zhi Peng, 2018, Annals of Oncology.